Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-33,205
Closed -$248K 3205
2023
Q1
$248K Sell
33,205
-287
-0.9% -$2.87K ﹤0.01% 2948
2022
Q4
$415K Sell
33,492
-2,078
-6% -$36.5K ﹤0.01% 2924
2022
Q3
$733K Sell
35,570
-46,041
-56% -$1.28M ﹤0.01% 2864
2022
Q2
$2.26M Sell
81,611
-82,238
-50% -$2.82M ﹤0.01% 2375
2022
Q1
$6.75M Buy
163,849
+11,171
+7% +$486K ﹤0.01% 1897
2021
Q4
$8.43M Sell
152,678
-4,976
-3% -$307K ﹤0.01% 1803
2021
Q3
$9.74M Buy
157,654
+3,116
+2% +$205K ﹤0.01% 1801
2021
Q2
$13.1M Buy
154,538
+21,853
+16% +$1.99M ﹤0.01% 1681
2021
Q1
$10.5M Buy
132,685
+13,316
+11% +$864K ﹤0.01% 1767
2020
Q4
$6.95M Buy
119,369
+29,596
+33% +$1.39M ﹤0.01% 1907
2020
Q3
$3.04M Sell
89,773
-9,806
-10% -$371K ﹤0.01% 2178
2020
Q2
$4.59M Buy
+99,579
New +$2.77M ﹤0.01% 1942

Other funds holding AFMD

Nuveen's AFMD Position: Q2 2023 in Review

Nuveen sold out of Affimed (AFMD) in Q2 2023, closing a stake of 33,205 shares — an estimated $248K sold.

Nuveen first reported a position in AFMD in Q2 2020 and held it in 12 quarters. The position peaked at $13.1M in Q2 2021. 80 funds tracked by Wall St. Rank hold AFMD as of Q2 2023.

  • Nuveen reported no remaining Affimed position as of Q2 2023 after selling out during the quarter.
  • Nuveen sold 33,205 Affimed shares in Q2 2023, an estimated $248K.
  • Nuveen first reported a position in Affimed in Q2 2020 and held it in 12 quarters.
  • Nuveen's Affimed position peaked at $13.1M in Q2 2021.
  • 80 funds tracked by Wall St. Rank held Affimed as of Q2 2023.

Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.